Life sciences veteran executive J.D. Mowery is the new chief executive officer at KBI Biopharma and Selexis SA. He succeeds Tim Lowery who was named CEO on an interim basis last November.
Read More
Durham Technical Community College and KBI Biopharma are launching an internship program designed to provide a “diverse talent pipeline” for biotech companies and to provide more “access to underutilized labor pools.”
Read More
The expansion is the latest growth spurt for KBI, which originated as a spinout of Atlanta life sciences company Kinetic Biosystems and located in Durham in 2003 with the help of a $1 million startup loan from the North Carolina Biotechnology Center.
Read More
KBI Biopharma is expanding its footprint in the Triangle, announcing plans Tuesday to build a $150 million manufacturing facility that will have positions for more than 200 jobs in operations and quality assurance.
Read More
https://wraltechwire.com/2018/05/09/kbi-biopharma-taking-office-and-lab-space-in-rtp-venture-at-imperial-center/
Read More
KBI Biopharma, a contract development and manufacturing company, is moving to offices and labs in the Venture at Imperial Center in Durham.
Read MoreAn upcoming forum will bring together leaders of North Carolina’s life science industry where they will discuss growth of biomanufacturing and advanced manufacturing facilities.
Read More
